Isolation of ginsenoside Rh1 and compound K from fermented ginseng and efficacy assessment on systemic anaphylactic shock

Food Science and Biotechnology

Volumn 17, Issue 4, 2008, Pages 805-808

  Mi, Soon Kim ^a   Kwon, Bin ^b   Myeong, Soo Park ^b,c   Geun, Eog Ji ^a,b  

^a Seoul National University   (South Korea)

^b BIFIDO Co   (South Korea)

^c Anyang Science University   (South Korea)

Author keywords

Anaphylactic shock model; Compound K; Ginsenoside Rh1

Indexed keywords

PANAX GINSENG;

EID: 56349137201     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hasegawa H. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 95: 153-157 (2004)
2. Chi H, Lee BH, Park MS, Ji GE. Differential transformation of ginsenosides from Panax ginseng by lactic acid bacteria. J. Microbiol. Biotechn. 16: 1629-1633 (2006)
3. Huong NT, Matsumoto K, Kasai R, Yamasaki K, Watanabe H. In vitro antioxidant activity of Vietnamese ginseng saponin and its component. Biol. Pharm. Bull. 21: 978-981 (1998)
4. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51: 1851-1858 (2002)
5. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull. 17: 635-639 (1994)
6. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-, and 20(S)-ginsenoside-Rg3, of red ginseng. Biol. Pharm. Bull. 18: 1197-1202 (1995)
7. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem. Bioph. Res. Co. 246: 725-730 (1998)
8. Zhang XM, Qu SC, Sui DY, Yu XF, Lv ZZ. Effects of ginsenoside-Rb on blood lipid metabolism and anti-oxidation in hyperlipidemia rats. Zhongguo Zhong Yao Za Zhi. 29: 1085-1088 (2004)
9. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol. Sinic. 26: 143-149 (2005)
10. Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H, Arichi S. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res. 45: 2781-2784 (1985)
11. Ota T, Fujikawa-yamamoto K, Zong Z, Yamazaki M, Odashirna S, Kitagawa I, Abe H, Arichi S. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res. 47: 3863-3867 (1987)
12. Park MT, Cha HJ, Jeong JW, Lee HY, Kim SI, Back NI, Kim OH, Kim KW. Anti-invasive activity of ginsenoside Rh1 and Rh2 in the HT1080 cells. J. Ginseng Res. 22: 216-221 (1998)
13. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Imm. 133: 113-120 (2004)
14. Shin JE, Park EK, Kim EJ, Hong YH, Lee KT, Kim DH. Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by bifidobacteria, against some tumor cells. J. Ginseng Res. 27: 129-134 (2003)
15. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28: 652-656 (2005)
16. Lee JY, Shin JW, Chun KS, Park KK, Chung WY, Bang YJ, Sung JH, Surh YJ. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 26: 359-367 (2005)
17. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Phamacol. 50: 1155-1160 (1998)
18. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsesnosides in humans after oral administration. Drug Metab. Dispos. 31: 1065-1071 (2003)
19. Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med. 64: 696-700 (1998)
20. Jiang S, Nakano Y, Yatsuzuka R, Ono R, Kamei C. Inhibitory effects of Moutan cortex on immediate allergic reactions. Biol. Pharm. Bull. 30: 1707-1710 (2007)
21. Kim SH, Kim SH, Kim SH, Moon JY, Park WH, Kim CH, Shin TY. Action of Dracocephalum argunense on mast cell-mediated allergy model. Biol. Pharm. Bull. 29: 494-498 (2006)
22. Kim SH, Shin TY. Effect of Dracocephalum argunense on mast-cell-mediated hypersensitivity. Int. Arch. Allergy Imm. 139: 87-95 (2006)
23. Jeong HJ, Koo HN, Myung NI, Shin MK, Kim JW, Kim DK, Kim KS, Kim HM, Lee YM. Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian ginseng. Immunopharm. Immunot. 23: 107-117 (2001)
24. Kim JY, Suh JW, Ji GE. Evaluation of S-adenosyl-L- methionine production by Bifidobacterium bifidum BGN4. Food Sci. Biotechnol. 17: 184-187 (2008)
25. Yang SO, Ji GE. Inhibitory effects of Ulmus parvifolia and Liriope platyphylla Wang et Tang on histamine release from rat peritoneal mast cells. Food Sci. Biotechnol. 15: 363-368 (2006)